Literature DB >> 2200689

Drug delivery systems and routes of administration of peptide and protein drugs.

L M Sanders1.   

Abstract

The unique requirements of peptides and proteins in designing delivery systems, and the unprecedented recent growth in the field, has driven a great deal of research into novel means of drug delivery. The search for approaches that provide formulations that are stable, bioavailable, readily manufacturable, and acceptable to the patient, has led to major advances in development of nasal and controlled release technology. The field of parenteral solution technology has also seen some new demands made of it, and what was formerly a conventional area of formulation technology has made scientific advances to meet the needs of these compounds. At the same time, strides are being made in fundamental research in areas including oral delivery, transdermal delivery, and pulsatile and 'on demand' delivery of peptides and proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200689     DOI: 10.1007/BF03190192

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  11 in total

1.  Development of an aerosol dosage form containing insulin.

Authors:  S W Lee; J J Sciarra
Journal:  J Pharm Sci       Date:  1976-04       Impact factor: 3.534

Review 2.  Alternative delivery systems for peptides and proteins as drugs.

Authors:  D A Eppstein; J P Longenecker
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1988       Impact factor: 4.889

3.  Facilitated transdermal transport of insulin.

Authors:  O Siddiqui; Y Sun; J C Liu; Y W Chien
Journal:  J Pharm Sci       Date:  1987-04       Impact factor: 3.534

4.  Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma.

Authors:  H Parmar; R H Phillips; S L Lightman; L Edwards; L Allen; A V Schally
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

Review 5.  Microcapsules as drug delivery devices.

Authors:  C Thies
Journal:  Crit Rev Biomed Eng       Date:  1982

6.  Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.

Authors:  L M Sanders; J S Kent; G I McRae; B H Vickery; T R Tice; D H Lewis
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

7.  Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement.

Authors:  H Okada; I Yamazaki; Y Ogawa; S Hirai; T Yashiki; H Mima
Journal:  J Pharm Sci       Date:  1982-12       Impact factor: 3.534

8.  Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.

Authors:  S R Ahmed; J Grant; S M Shalet; A Howell; S D Chowdhury; T Weatherson; N J Blacklock
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

9.  Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics.

Authors:  W D Rhine; D S Hsieh; R Langer
Journal:  J Pharm Sci       Date:  1980-05       Impact factor: 3.534

10.  Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer.

Authors:  L M Sanders; B A Kell; G I McRae; G W Whitehead
Journal:  J Pharm Sci       Date:  1986-04       Impact factor: 3.534

View more
  9 in total

1.  Absorbable collagen sponge combined with recombinant human basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve.

Authors:  Cheng-Can Yao; Ping Yao; Hao Wu; Zhen-Gang Zha
Journal:  J Mater Sci Mater Med       Date:  2007-06-07       Impact factor: 3.896

2.  Oral absorption of peptides through the cobalamin (vitamin B12) pathway in the rat intestine.

Authors:  J Alsenz; G J Russell-Jones; S Westwood; B Levet-Trafit; P C de Smidt
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

Review 3.  Interleukins. Clinical pharmacokinetics and practical implications.

Authors:  V Bocci
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

4.  Effect of additives on the release of a model protein from PLGA microspheres.

Authors:  F Kang; J Singh
Journal:  AAPS PharmSciTech       Date:  2001-12-17       Impact factor: 3.246

5.  Transport of low and high molecular peptides across rabbit Peyer's patches.

Authors:  S Haseto; H Ouchi; T Isoda; T Mizuma; M Hayashi; S Awazu
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

6.  Plasma concentration of metformin and dexamethasone after administration through Osseogate.

Authors:  Hong-Kyun Kim; Young-Seok Park
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular endothelial cells.

Authors:  Afshan Afsar Khan; Arghya Paul; Sana Abbasi; Satya Prakash
Journal:  Int J Nanomedicine       Date:  2011-05-24

8.  Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline.

Authors:  Alireza Mahboubian; Seyyed Kazem Hashemein; Shadi Moghadam; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

9.  Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system.

Authors:  S Ravi; K K Peh; Yusrida Darwis; B Krishna Murthy; T Raghu Raj Singh; C Mallikarjun
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.